Abstract
The US Food and Drug Administration has approved an Ebola vaccine for the first time. The vaccine, Ervebo, is produced by Merck & Co. and was tested during a recent outbreak in West Africa. It has been administered more than 223,000 times during the current outbreak in the Democratic Republic of the Congo, where it is being used on an experimental basis. Ervebo is made from a live but weakened virus engineered to express an Ebola protein. The European Commission previously approved the vaccine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
